CAK inhibitors and uses thereof

Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Transferase other than ribonuclease

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S267000, C514S279000, C514S283000

Reexamination Certificate

active

07078209

ABSTRACT:
The present invention relates to compounds useful as inhibitors of CAK, compositions thereof. The present invention also relates to methods using the compositions for treating CAK-mediated diseases, such as fungal infections.

REFERENCES:
patent: 5091537 (1992-02-01), Fischer et al.
patent: 5705350 (1998-01-01), Mudryj et al.
patent: 0 404 190 (1990-12-01), None
Pauls, H., et al., “Umsetzungen mit CH-aciden Verbindungen and Übergang in Indolizine,”Chemische Berichten, 10:1294-1303 (1997).
Mezentseva, M.V., et al., “Synthesis and Antitumor Activity of Pyrrolo [3,2-d] Pyrimidines,”Pharmaceutical Chemistry Journal, 25:858-864 (1991).
Sato, K., et al., “Studies of heterocyclic compound. XI. The synthesis of oxazolo [3,2-b] pyridazinium perchlorates and their reactions with some C-nucleophiles”,Chemical abstract, 87(13), abstract No. 102255a, (1977).
Abd el Salam, O., “Synthesis of some new pyrimido [5,4-a] indolizines,”Monatshefte für Chemie, 131:959-965 (Sep. 2000).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

CAK inhibitors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CAK inhibitors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CAK inhibitors and uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3581098

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.